CRDF
Cardiff Oncology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$105.29M
P/E Ratio
—
EPS
$-0.67
Beta
1.38
52W High
$4.56
52W Low
$1.35
50-Day MA
$1.66
200-Day MA
$2.04
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cardiff Oncology Inc
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 525,000 |
| Gross Profit (TTM) | $-31.09M |
| EBITDA | $-47.07M |
| Operating Margin | -31341.00% |
| Return on Equity | -84.80% |
| Return on Assets | -44.30% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.51 |
| Price-to-Book | 3.06 |
| Price-to-Sales (TTM) | 200.55 |
| EV/Revenue | 116.01 |
| EV/EBITDA | -3.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.40% |
| Shares Outstanding | $68.37M |
| Float | $66.71M |
| % Insiders | 5.91% |
| % Institutions | 32.85% |
Historical Volatility
HV 10-Day
152.64%
HV 20-Day
118.72%
HV 30-Day
99.89%
HV 60-Day
81.58%
HV Rank
75.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.36 target)
1
Strong Buy6
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026